The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function

@article{Ahrens2009TheNC,
  title={The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function},
  author={J{\"o}rg Ahrens and Reyhan Demir and Martin Leuwer and Jeanne de la Roche and Klaus Krampfl and Nilufar Foadi and Matthias Karst and Gertrud Haeseler},
  journal={Pharmacology},
  year={2009},
  volume={83},
  pages={217 - 222}
}
Loss of inhibitory synaptic transmission within the dorsal horn of the spinal cord plays a key role in the development of chronic pain following inflammation or nerve injury. Inhibitory postsynaptic transmission in the adult spinal cord involves mainly glycine. Cannabidiol is a nonpsychotropic plant constituent of Cannabis sativa. As we hypothesized that non-CB receptor mechanisms of cannabidiol might contribute to its anti-inflammatory and neuroprotective effects, we investigated the… Expand
Nonpsychoactive Cannabinoid Action on 5-HT3 and Glycine Receptors
The 5-HT3 and glycine receptors are pentameric ion channels belonging to a Cys-loop ligand-gated ion channel superfamily. While the glycine receptors can mediate fast inhibitory synapticExpand
Lack of positive allosteric modulation of mutated α1S267I glycine receptors by cannabinoids
TLDR
This study investigated the impact of the amino acid residue serine at position 267 on the glycine-modulatory effects of ajulemic acid, cannabidiol and HU210 and found that the mutation of the α1 subunit TM2 serine residue to isoleucine abolished the co-activation and the direct activation of the glyine receptor by the investigated cannabinoids. Expand
Therapeutic Potential of Nonpsychoactive Cannabinoids by Targeting at Glycine Receptors
TLDR
Recent development in studies of mechanism and therapeutic potential of cannabinoid modu‐ lation of GlyR subunits shows considerable promise toward the development of novel therapeutic agents acting at defined modulatory sites of GlyRs in the treatment of various chronic pain, neuromotor disorders, and other GlyR deficiency diseases. Expand
Paracetamol Fails to Positively Modulate and Directly Activate Chloride Currents in Human α1-Glycine Receptors
TLDR
The analgesic actions of paracetamol leading to pain relief appear to be mediated via other mechanisms, but not via activation of spinal glycinergic pathways. Expand
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.
TLDR
Using mutagenesis and NMR analysis, a serine at 296 in the GlyR protein critical for the potentiation of I(Gly) by Δ(9)-tetrahydrocannabinol (THC), a major psychoactive component of marijuana is identified. Expand
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors.
TLDR
CBD inhibits the function of the α7-nACh receptor, a cloned α7 subunit of the human nicotinic acetylcholine (α7 nACh) receptor expressed in Xenopus oocytes, and phytocannabinoids such as cannabinol and Δ(9)-tetrahydrocannabinol did not affect ACh-induced currents. Expand
Modulation of Glycine Receptor-Mediated Pain Signaling in vitro and in vivo by Glucose
TLDR
Glucose showed mild analgesic effects and was able to compensate for strychnine-induced allodynia in mice and suggest a molecular mechanism for glucose-mediated analgesia. Expand
Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
TLDR
Cannabidiol displays antagonist-like activity toward σ1R to reduce the negative effects of NMDAR overactivity in the abovementioned experimental situations. Expand
A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors
TLDR
Sustained incubation with the endocannabinoid anandamide substantially increased the amplitude of glycine-activated current in both rat cultured spinal neurons and in HEK-293 cells expressing human α1, rat α2 and α3 GlyRs, suggesting that exogenous and endogenous cannabinoids potentiate GlyRs via a hydrogen bonding-like interaction. Expand
Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians
  • S. Narouze
  • Medicine
  • Regional Anesthesia & Pain Medicine
  • 2020
TLDR
This narrative review evaluates cannabinoids’ diverse mechanisms of action as it pertains to nociception modulation relevant to the practice of anesthesiologists and pain medicine physicians. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
TLDR
It is concluded that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects. Expand
Δ9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors
TLDR
The results indicate that THC and AEA, in pharmacologically relevant concentrations, directly potentiate the function of GlyRs through an allosteric mechanism. Expand
The glycinergic control of spinal pain processing
  • H. Zeilhofer
  • Medicine
  • Cellular and Molecular Life Sciences CMLS
  • 2005
TLDR
The central component of inflammatory pain originates from a disinhibition of dorsal horn neurons, which are relieved from glycinergic neurotransmission by the inflammatory mediator prostaglandin E2 (PGE2). Expand
[The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].
TLDR
The data allow us to suggest the existence of a CB1R independent action of cannabinoids directly on glycine-activated currents, representing a novel antinociceptive mechanism of this compounds. Expand
Reversal of pathological pain through specific spinal GABAA receptor subtypes
TLDR
It is shown that their selective activation by the non-sedative (‘α1-sparing’) benzodiazepine-site ligand L-838,417 is highly effective against inflammatory and neuropathic pain yet devoid of unwanted sedation, motor impairment and tolerance development. Expand
The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors.
TLDR
Comparing the EC50 values reported here with free plasma concentrations during steroid-induced anaesthesia indicates that a selective modulation of GABAA receptor activity is likely to occur in vivo. Expand
Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?
TLDR
Recent developments in GlyR pharmacology are discussed, the receptor domains that are involved in binding of agonists and allosteric modulators are delineated, and a molecular model of the extracellular architecture of the receptor is presented. Expand
On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
  • B. Costa
  • Medicine
  • Chemistry & biodiversity
  • 2007
TLDR
Emerging evidence highlights the beneficial effects of the whole cannabis extract over those observed with single components, indicating cannabis-based medicines as new perspective to revisit the pharmacology of this plant. Expand
Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors
TLDR
Observations support the idea that anaesthetics exert a specific effect on these ion-channel proteins, and allow for the future testing of specific hypotheses of the action of anaesthetic action. Expand
On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC)
Cannabis is one of the first plants used as medicine, and the notion that it has potentially valuable therapeutic properties is a matter of current debate. The isolation of its main constituent,Expand
...
1
2
3
...